These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24528283)

  • 1. Challenges for opioid receptor nomenclature: IUPHAR Review 9.
    Cox BM; Christie MJ; Devi L; Toll L; Traynor JR
    Br J Pharmacol; 2015 Jan; 172(2):317-23. PubMed ID: 24528283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor trafficking and interaction in nociceptors.
    Zhang X; Bao L; Li S
    Br J Pharmacol; 2015 Jan; 172(2):364-74. PubMed ID: 24611685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.
    Burford NT; Traynor JR; Alt A
    Br J Pharmacol; 2015 Jan; 172(2):277-86. PubMed ID: 24460691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
    Knapman A; Connor M
    Br J Pharmacol; 2015 Jan; 172(2):349-63. PubMed ID: 24527749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances on the δ opioid receptor: from trafficking to function.
    Gendron L; Mittal N; Beaudry H; Walwyn W
    Br J Pharmacol; 2015 Jan; 172(2):403-19. PubMed ID: 24665909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo opioid receptor heteromerization: where do we stand?
    Massotte D
    Br J Pharmacol; 2015 Jan; 172(2):420-34. PubMed ID: 24666391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic synergy between opioid and α2 -adrenoceptors.
    Chabot-Doré AJ; Schuster DJ; Stone LS; Wilcox GL
    Br J Pharmacol; 2015 Jan; 172(2):388-402. PubMed ID: 24641506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation.
    Mann A; Illing S; Miess E; Schulz S
    Br J Pharmacol; 2015 Jan; 172(2):311-6. PubMed ID: 24517854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The μ-opioid receptor: an electrophysiologist's perspective from the sharp end.
    Henderson G
    Br J Pharmacol; 2015 Jan; 172(2):260-7. PubMed ID: 24640948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel GPCR paradigms at the μ-opioid receptor.
    Thompson GL; Kelly E; Christopoulos A; Canals M
    Br J Pharmacol; 2015 Jan; 172(2):287-96. PubMed ID: 24460711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
    Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
    Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying ligand-specific signalling within biased responses: focus on δ opioid receptor ligands.
    Charfi I; Audet N; Bagheri Tudashki H; Pineyro G
    Br J Pharmacol; 2015 Jan; 172(2):435-48. PubMed ID: 24665881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of opioid processes in reward and decision-making.
    Laurent V; Morse AK; Balleine BW
    Br J Pharmacol; 2015 Jan; 172(2):449-59. PubMed ID: 24930675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of δ-opioid receptors in learning and memory underlying the development of addiction.
    Klenowski P; Morgan M; Bartlett SE
    Br J Pharmacol; 2015 Jan; 172(2):297-310. PubMed ID: 24641428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons.
    Sadeghi M; Tzschentke TM; Christie MJ
    Br J Pharmacol; 2015 Jan; 172(2):460-8. PubMed ID: 24372103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
    Connor M; Bagley EE; Chieng BC; Christie MJ
    Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. So what do we call GPR18 now?
    Alexander SP
    Br J Pharmacol; 2012 Apr; 165(8):2411-3. PubMed ID: 22014123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. κ Opioid receptor ligands regulate angiogenesis in development and in tumours.
    Yamamizu K; Hamada Y; Narita M
    Br J Pharmacol; 2015 Jan; 172(2):268-76. PubMed ID: 24417697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.